title: [Skin manifestations in lupus erythematosus: clinical aspects and therapy].
abstract: Lupus erythematosus (LE) is an inflammatory autoimmune disorder, which is characterized by clinically heterogeneous manifestations of different organs. In systemic LE (SLE) the skin, the musculoskeletal system, the kidneys, the cardiovascular and central nervous systems can be involved. The skin lesions can be divided into LE-specific and LE-non-specific manifestations, the former represent the subtypes of cutaneous LE (CLE). The diagnosis is confirmed by clinical, histopathological, immunoserological and genetic features. The treatment is similar for the different subtypes of CLE; however, the therapeutic regimen should be individually defined in each patient. Antimalarials are still the first-line systemic therapy and in addition to sunscreens, glucocorticosteroids and calcineurin inhibitors have an important impact as topical agents in this disease.
authors.affiliation: Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster, Münster, Deutschland. kuhnan@uni-muenster.de
authors.forename: A
authors.initials: A
authors.lastname: Kuhn
authors.forename: V
authors.initials: V
authors.lastname: Ruland
authors.forename: G
authors.initials: G
authors.lastname: Bonsmann
mesh_terms: D000287:Administration, Topical; D000962:Antimalarials / Q000008:administration & dosage*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy*; D013473:Sunscreening Agents / Q000008:administration & dosage*
chemical_list: D000962:Antimalarials; D005938:Glucocorticoids; D013473:Sunscreening Agents